Director/PDMR Shareholding - Replacement
RNS Number : 2527Q
Nippon Active Value Fund PLC
16 October 2023
 

Nippon Active Value Fund plc (the "Company")

 

 

GENERAL TEXT AMENDMENT

 

The following amendment(s) has (have) been made to the Director/ PDMR Shareholding announcement released on 16 October 2023 at (10:57) under RNS No 2494Q.

 

Purchase price changed to 155.562426p.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Director/PDMR Shareholding

 

16 October 2023

 

The relevant notifications set out below are provided in accordance with the requirements of the Market Abuse Regulation.

 

Enquiries:

 

Apex Listed Companies Services (UK) Limited

020 3327 9720

Company Secretary


 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 Noel Lamb

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Nippon Active Value Fund plc

b)

 

LEI

 

 

213800JOFEGZJYS21P75

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 



Identification code

ISIN: GB00BKLGLS10



b)

 

Nature of the transaction

 

 

Acquisition of shares  

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




155.562426p. per share

11,951




155.562426p. per share

23,902







d)

 

Aggregated information




- Aggregated volume

35,853



- Price

Total price £30,000



e)

 

Date of the transaction

 

 

16 October 2023

f)

 

Place of the transaction

 

 

London

 

End

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEEKFEPDFFA